Louisiana Attorney General Files Consumer Protection Lawsuit Regarding Recalled Dialysis Drugs – GranuFlo and NaturaLyte

Seal_of_Louisiana_2010.pngLouisiana Attorney General James “Buddy” Caldwell filed a lawsuit on June 27, 2014 with the 19th Judicial District Court for the Parish of East Baton Rouge against Fresenius Medical Care North America and its Louisiana dialysis clinics over the use of dialysis drugs, GranuFlo and NaturaLyte. The FDA issued a Class I recall on these drugs after it was found that the products could put patients at risk for cardiac arrest when not prescribed appropriately.

The Attorney General’s lawsuit seeks a return of profit made by Fresenius on the sale of these drug in Louisiana and seeks civil penalties of up to $5,000 per violation under Louisiana’s Unfair Trade Practices and Consumer Protection Law, La. R.S. 51:1401, et seq.

A number of class-action lawsuits have also been filed against Fresenius. The federal lawsuits have been consolidated into Multi District Litigation (MDL) 2428: In Re: Fresenius Granuflo/Naturalyte Dialysate Products Liability Litigation in the United States District Court for the District of Massachusetts.

If you or a loved one suffered a heart attack while receiving dialysis at a Fresenius Medical Center dialysis clinic, contact Scott Andrews at the Baton Rouge, Louisiana drug injury law firm of Dué, Guidry, Piedrahita & Andrews to schedule a free consultation.